484 related articles for article (PubMed ID: 24351443)
1. Noninvasive prenatal detection of aneuploidy.
Robinson C; van den Boom D; Bombard AT
Clin Obstet Gynecol; 2014 Mar; 57(1):210-25. PubMed ID: 24351443
[TBL] [Abstract][Full Text] [Related]
2. Genomic medicine in prenatal diagnosis.
South ST; Chen Z; Brothman AR
Clin Obstet Gynecol; 2008 Mar; 51(1):62-73. PubMed ID: 18303500
[TBL] [Abstract][Full Text] [Related]
3. The role of noninvasive prenatal testing as a diagnostic versus a screening tool--a cost-effectiveness analysis.
Ohno M; Caughey A
Prenat Diagn; 2013 Jul; 33(7):630-5. PubMed ID: 23674316
[TBL] [Abstract][Full Text] [Related]
4. Non-invasive chromosome test raises new questions in prenatal diagnosis about the significance of ultrasound and questions about new screening strategies.
Tercanli S; Vial Y; Merz E
Ultraschall Med; 2013 Oct; 34(5):417-20. PubMed ID: 24127381
[No Abstract] [Full Text] [Related]
5. Noninvasive prenatal testing: impact on genetic counseling, invasive prenatal diagnosis, and trisomy 21 detection.
Wax JR; Cartin A; Chard R; Lucas FL; Pinette MG
J Clin Ultrasound; 2015 Jan; 43(1):1-6. PubMed ID: 25303161
[TBL] [Abstract][Full Text] [Related]
6. The consequences of implementing non-invasive prenatal testing in Dutch national health care: a cost-effectiveness analysis.
Beulen L; Grutters JP; Faas BH; Feenstra I; van Vugt JM; Bekker MN
Eur J Obstet Gynecol Reprod Biol; 2014 Nov; 182():53-61. PubMed ID: 25238658
[TBL] [Abstract][Full Text] [Related]
7. National decline in invasive prenatal diagnostic procedures in association with uptake of combined first trimester and cell-free DNA aneuploidy screening.
Robson SJ; Hui L
Aust N Z J Obstet Gynaecol; 2015 Oct; 55(5):507-10. PubMed ID: 26259499
[TBL] [Abstract][Full Text] [Related]
8. Uptake of noninvasive prenatal testing at a large academic referral center.
Larion S; Warsof SL; Romary L; Mlynarczyk M; Peleg D; Abuhamad AZ
Am J Obstet Gynecol; 2014 Dec; 211(6):651.e1-7. PubMed ID: 24954652
[TBL] [Abstract][Full Text] [Related]
9. From Down syndrome screening to noninvasive prenatal testing: 20 years' experience in Taiwan.
Shaw SW; Chen CP; Cheng PJ
Taiwan J Obstet Gynecol; 2013 Dec; 52(4):470-4. PubMed ID: 24411028
[TBL] [Abstract][Full Text] [Related]
10. Reliable noninvasive prenatal testing by massively parallel sequencing of circulating cell-free DNA from maternal plasma processed up to 24h after venipuncture.
Buysse K; Beulen L; Gomes I; Gilissen C; Keesmaat C; Janssen IM; Derks-Willemen JJ; de Ligt J; Feenstra I; Bekker MN; van Vugt JM; Geurts van Kessel A; Vissers LE; Faas BH
Clin Biochem; 2013 Dec; 46(18):1783-6. PubMed ID: 23933476
[TBL] [Abstract][Full Text] [Related]
11. Current controversies in prenatal diagnosis 1: should noninvasive DNA testing be the standard screening test for Down syndrome in all pregnant women?
Bianchi DW; Oepkes D; Ghidini A
Prenat Diagn; 2014 Jan; 34(1):6-11. PubMed ID: 24002925
[No Abstract] [Full Text] [Related]
12. [Value of detection of cell-free fetal DNA in maternal plasma in the prenatal diagnosis of chromosomal abnormalities].
Wang SJ; Gao ZY; Lu YP; Li YL; You YQ; Zhang LW; Wang LX; Xu H
Zhonghua Fu Chan Ke Za Zhi; 2012 Nov; 47(11):808-12. PubMed ID: 23302119
[TBL] [Abstract][Full Text] [Related]
13. What Is New in Prenatal Aneuploidy Screening?: Best Articles From the Past Year.
Norton ME
Obstet Gynecol; 2015 Jul; 126(1):211-2. PubMed ID: 26241275
[TBL] [Abstract][Full Text] [Related]
14. The impact of noninvasive prenatal testing on the practice of maternal-fetal medicine.
Friel LA; Czerwinski JL; Singletary CN
Am J Perinatol; 2014 Oct; 31(9):759-64. PubMed ID: 24338115
[TBL] [Abstract][Full Text] [Related]
15. Down syndrome: prenatal risk assessment and diagnosis.
Newberger DS
Am Fam Physician; 2000 Aug; 62(4):825-32, 837-8. PubMed ID: 10969860
[TBL] [Abstract][Full Text] [Related]
16. Sex chromosome aneuploidy detection by noninvasive prenatal testing: helpful or hazardous?
Reiss RE; Discenza M; Foster J; Dobson L; Wilkins-Haug L
Prenat Diagn; 2017 May; 37(5):515-520. PubMed ID: 28326560
[TBL] [Abstract][Full Text] [Related]
17. Have we done our last amniocentesis? Updates on cell-free DNA for Down syndrome screening.
Gray KJ; Wilkins-Haug LE
Pediatr Radiol; 2018 Apr; 48(4):461-470. PubMed ID: 29550862
[TBL] [Abstract][Full Text] [Related]
18. Changing indications for invasive testing in an era of improved screening.
Norton ME; Rink BD
Semin Perinatol; 2016 Feb; 40(1):56-66. PubMed ID: 26725145
[TBL] [Abstract][Full Text] [Related]
19. Complete trisomy 21 vs translocation Down syndrome: a comparison of modes of ascertainment.
Bornstein E; Lenchner E; Donnenfeld A; Jodicke C; Keeler SM; Kapp S; Divon MY
Am J Obstet Gynecol; 2010 Oct; 203(4):391.e1-5. PubMed ID: 20691415
[TBL] [Abstract][Full Text] [Related]
20. Prenatal screening and diagnosis of aneuploidy in multiple pregnancies.
Gagnon A; Audibert F
Best Pract Res Clin Obstet Gynaecol; 2014 Feb; 28(2):285-94. PubMed ID: 24485166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
